157 related articles for article (PubMed ID: 18343835)
21. Antisense therapy of influenza.
Abe T; Mizuta T; Hatta T; Miyano-Kurosaki N; Fujiwara M; Takai K; Shigeta S; Yokota T; Takaku H
Eur J Pharm Sci; 2001 Apr; 13(1):61-9. PubMed ID: 11292569
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of porcine reproductive and respiratory syndrome virus infection in piglets by a peptide-conjugated morpholino oligomer.
Opriessnig T; Patel D; Wang R; Halbur PG; Meng XJ; Stein DA; Zhang YJ
Antiviral Res; 2011 Jul; 91(1):36-42. PubMed ID: 21554902
[TBL] [Abstract][Full Text] [Related]
23. Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.
Greenberg DE; Marshall-Batty KR; Brinster LR; Zarember KA; Shaw PA; Mellbye BL; Iversen PL; Holland SM; Geller BL
J Infect Dis; 2010 Jun; 201(12):1822-30. PubMed ID: 20438352
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals.
Leneva IA; Goloubeva O; Fenton RJ; Tisdale M; Webster RG
Antimicrob Agents Chemother; 2001 Apr; 45(4):1216-24. PubMed ID: 11257037
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site.
Yuan J; Stein DA; Lim T; Qiu D; Coughlin S; Liu Z; Wang Y; Blouch R; Moulton HM; Iversen PL; Yang D
J Virol; 2006 Dec; 80(23):11510-9. PubMed ID: 16987987
[TBL] [Abstract][Full Text] [Related]
26. Peptide-conjugated morpholino oligomers inhibit porcine reproductive and respiratory syndrome virus replication.
Patel D; Opriessnig T; Stein DA; Halbur PG; Meng XJ; Iversen PL; Zhang YJ
Antiviral Res; 2008 Feb; 77(2):95-107. PubMed ID: 17959259
[TBL] [Abstract][Full Text] [Related]
27. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection.
Bahgat MM; Błazejewska P; Schughart K
Virol J; 2011 Jan; 8():27. PubMed ID: 21251300
[TBL] [Abstract][Full Text] [Related]
29. Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus.
Endo A; Itamura S; Iinuma H; Funahashi S; Shida H; Koide F; Nerome K; Oya A
J Gen Virol; 1991 Mar; 72 ( Pt 3)():699-703. PubMed ID: 2005435
[TBL] [Abstract][Full Text] [Related]
30. Intranasal Delivery of Peptide-Morpholinos to Knockdown Influenza Host Factors in Mice.
Rajsbaum R
Methods Mol Biol; 2017; 1565():191-199. PubMed ID: 28364244
[TBL] [Abstract][Full Text] [Related]
31. Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge.
Jimenez GS; Planchon R; Wei Q; Rusalov D; Geall A; Enas J; Lalor P; Leamy V; Vahle R; Luke CJ; Rolland A; Kaslow DC; Smith LR
Hum Vaccin; 2007; 3(5):157-64. PubMed ID: 17637571
[TBL] [Abstract][Full Text] [Related]
32. Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine.
Anhlan D; Hrincius ER; Scholtissek C; Ludwig S
Vaccine; 2012 Jun; 30(30):4480-9. PubMed ID: 22575164
[TBL] [Abstract][Full Text] [Related]
33. Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target.
Davis AM; Ramirez J; Newcomb LL
Virol J; 2017 Feb; 14(1):22. PubMed ID: 28173821
[TBL] [Abstract][Full Text] [Related]
34. Expression of a single siRNA against a conserved region of NP gene strongly inhibits in vitro replication of different Influenza A virus strains of avian and swine origin.
Stoppani E; Bassi I; Dotti S; Lizier M; Ferrari M; Lucchini F
Antiviral Res; 2015 Aug; 120():16-22. PubMed ID: 25986248
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers.
Nan Y; Ma Z; Kannan H; Stein DA; Iversen PI; Meng XJ; Zhang YJ
Antiviral Res; 2015 Aug; 120():134-9. PubMed ID: 26086884
[TBL] [Abstract][Full Text] [Related]
36. Behaviour of influenza A viruses differentially expressing segment 2 gene products in vitro and in vivo.
Tauber S; Ligertwood Y; Quigg-Nicol M; Dutia BM; Elliott RM
J Gen Virol; 2012 Apr; 93(Pt 4):840-849. PubMed ID: 22190016
[TBL] [Abstract][Full Text] [Related]
37. Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant.
Zheng M; Liu F; Shen Y; Wang S; Xu W; Fang F; Sun B; Xie Z; Chen Z
Hum Vaccin Immunother; 2015; 11(2):397-406. PubMed ID: 25607884
[TBL] [Abstract][Full Text] [Related]
38. Disruption of the viral polymerase complex assembly as a novel approach to attenuate influenza A virus.
Mänz B; Götz V; Wunderlich K; Eisel J; Kirchmair J; Stech J; Stech O; Chase G; Frank R; Schwemmle M
J Biol Chem; 2011 Mar; 286(10):8414-8424. PubMed ID: 21183679
[TBL] [Abstract][Full Text] [Related]
39. Influenza virion-derived viral ribonucleoproteins synthesize both mRNA and cRNA in vitro.
Vreede FT; Brownlee GG
J Virol; 2007 Mar; 81(5):2196-204. PubMed ID: 17166911
[TBL] [Abstract][Full Text] [Related]
40. Antisense oligonucleotides targeting the RNA binding region of the NP gene inhibit replication of highly pathogenic avian influenza virus H5N1.
Zhang T; Wang TC; Zhao PS; Liang M; Gao YW; Yang ST; Qin C; Wang CY; Xia XZ
Int Immunopharmacol; 2011 Dec; 11(12):2057-61. PubMed ID: 21933722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
